Terug

Watch Compare

Catheter Precision, Inc.

Datakwaliteit: 100%

VTAK

NYSE Manufacturing Measuring & Analyzing Instruments

€ 1,03

▼ € 0,10 (-8,85%)

6 months return

—

Momentum

Neutral

5Y revenue growth

147,01%

Groei

Revenue Growth (5Y)

147,01%

Boven sectorgemiddelde (1,82%)

Revenue (1Y)95,00%

Earnings (1Y)N/A

FCF Growth (3Y)N/A

Kwaliteit

Return on Equity

-253,23%

Onder sectorgemiddelde (-54,47%)

ROIC-81,34%

Net Margin-2098,05%

Op. Margin-2581,56%

Veiligheid

Debt / Equity

0,22

Onder sectorgemiddelde (0,30)

Current Ratio0,46

Interest CoverageN/A

Waardering

PE (TTM)

-0,19

Boven sectorgemiddelde (-1,49)

P/B Ratio0,48

EV/EBITDAN/A

Dividend YieldN/A

Quick Summary

Key Takeaways

Short bullets derived from reported financials—not the AI summary above.

Revenue grew 147,01% annually over 5 years — strong growth

Debt/Equity of 0,22 — conservative balance sheet

Negative free cash flow of -8,31 M

Revenue growth is decelerating — 1Y growth trails 5Y average by 52,01%

Capital efficient — spends only 2,08% of revenue on capex

Price History

Financiële Trends

Koersdoel Analisten

Geen analistendekking beschikbaar

Winstverassingen

EPS

Reported Estimate

	Q12024	Q22024	Q32024	Q42024
Reported	-€ 68,40	-€ 105,83	-€ 38,19	—
Estimate	-€ 7,98	-€ 4,94	—	-€ 3,80
Verrassing	-757,14%	-2042,31%	—	—

Growth

Rev 5Y: 147,01% · Earnings 1Y: N/A

Revenue Growth (1Y)	95,00%	Revenue Growth (3Y)	36,12%
Earnings Growth (1Y)	N/A	Earnings Growth (3Y)	N/A
Revenue Growth (5Y)	147,01%	Earnings Growth (5Y)	N/A

Profitability

ROE: -253,23% · Net Margin: -2098,05%

Revenue (TTM)	819.000,0	Net Income (TTM)	-17,18 M
ROE	-253,23%	ROA	-67,34%
Gross Margin	92,31%	Operating Margin	-2581,56%
Net Margin	-2098,05%	Free Cash Flow (TTM)	-8,31 M
ROIC	-81,34%	FCF Growth (3Y)	N/A

Safety

D/E: 0,22 · Current: 0,46

Debt / Equity	0,22	Current Ratio	0,46
Interest Coverage	N/A	Asset Turnover	0,03
Working Capital	-2,86 M	Tangible Book Value	-15,96 M

Dividends

Yield: N/A · Payout: N/A

Dividend Yield	N/A	Payout Ratio	N/A
Dividend Growth (3Y)	N/A	Dividend Growth (5Y)	N/A
Consecutive Div Years	N/A

Valuation

P/E: -0,19 · EV/EBITDA: N/A

P/E Ratio	-0,19	Forward P/E	N/A
P/B Ratio	0,48	P/S Ratio	3,95
PEG Ratio	N/A	Forward PEG	N/A
EV/EBITDA	N/A	Fwd EV/EBITDA	N/A
Forward P/S	N/A	Fwd Earnings Yield	N/A
FCF Yield	-257,29%
Market Cap	3,23 M	Enterprise Value	3,66 M

Per Share

EPS: N/A · FCF/Share: -3,09

EPS (Diluted TTM)	N/A	Revenue / Share	0,30
FCF / Share	-3,09	OCF / Share	-3,08
EPS CAGR (1Y)	N/A	EPS CAGR (5Y)	N/A
EPS CAGR (10Y)	N/A

Efficiency

FCF Conv: 48,38% · CapEx/Rev: 2,08%

CapEx / Revenue	2,08%	FCF Conversion	48,38%
SBC-Adj. FCF	-8,59 M	Growth Momentum	-52,01

Income Statement

Annual, most recent first

Metric	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue	819.000,0	420.000,0	442.000,0	14.000,0	22.000,0
Net Income	-17,18 M	-16,64 M	-70,57 M	-26,87 M	-25,07 M
EPS (Diluted)	—	—	—	-25,98	—
Gross Profit	756.000,0	378.000,0	412.000,0	-147.000,0	-1,54 M
Operating Income	-21,14 M	-11,24 M	-78,12 M	-26,96 M	-29,27 M
EBITDA	—	—	—	—	—
R&D Expenses	—	272.000,0	475.000,0	6,39 M	12,25 M
SG&A Expenses	12,08 M	11,35 M	17,12 M	16,25 M	15,48 M
D&A	2,12 M	2,11 M	2,08 M	421.000,0	1,57 M
Interest Expense	—	—	—	—	—
Income Tax	-1,81 M	3,14 M	0,0	3.000,0	4.000,0

Balance Sheet

Annual, most recent first

Metric	FY2025	FY2024	FY2023	FY2022	FY2021
Total Assets	15,86 M	27,77 M	30,74 M	16,84 M	21,04 M
Total Liabilities	9,21 M	16,01 M	9,54 M	7,58 M	7,37 M
Shareholders' Equity	7,05 M	11,76 M	21,19 M	9,26 M	13,67 M
Total Debt	3,08 M	—	—	—	—
Cash & Equivalents	88.000,0	2,87 M	—	15,86 M	15,05 M
Current Assets	390.000,0	3,29 M	4,16 M	16,84 M	17,09 M
Current Liabilities	3,91 M	2,09 M	2,47 M	7,58 M	5,39 M

Sectorvergelijking

vs Manufacturing sector mediaan (1605 peers)

Metriek	Aandeel	Sector Mediaan
P/E	-0,2	-1,5
P/B	0,5	1,6
ROE %	-253,2	-54,5
Net Margin %	-2098,1	-41,5
Rev Growth 5Y %	147,0	1,8
D/E	0,2	0,3